0.00Open0.00Pre Close0 Volume0 Open Interest5.00Strike Price0.00Turnover0.00%IV810.75%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier26DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.73Leverage Ratio--Theta--Rho--Eff Leverage--Vega
AlloVir Stock Discussion
AlloVir and Kalaris Therapeutics Announce Agreement for Transformational Merger to Create Company Focused on Diseases of the Retina
AlloVir has announced a merger with Kalaris Therapeutics in an all-stock transaction. The combined company will focus on developing TH103, a novel anti-VEGF therapy for retinal diseases, invented by Dr. Napoleone Ferrara. After the merger, pre-Merger AlloVir stockholders will own 25.05% and Kalaris stockholders 74.95% of the combined company. ...
Moomoo 24/7· 1 min ago
$Root Inc (ROOT.US)$ $Applied Optoelectronics (AAOI.US)$ $Transcode Therapeutics (RNAZ.US)$ $ShiftPixy (PIXY.US)$ $BranchOut Food (BOF.US)$ $Talaris Therapeutics (TALS.US)$ $Panbela Therapeutics (PBLA.US)$ $AlloVir (ALVR.US)$ $Iveda Solutions (IVDA.US)$ $Locafy (LCFY.US)$
Investment firm Rosenblatt downgraded $Twitter (Delisted) (TWTR.US)$ on Wednesday as the debate surrounding the whistleblower complaint from its former head of security has raised the risks surrounding the stock. Analyst Barton Crockett lowered his rating to neutral from buy and lowered his price target to $37 from $52, noting there are now "meaningful uncertainties" surr...
In reaction to earnings/guidance:
• $Teva Pharmaceutical Industries (TEVA.US)$ +24%(also announces agreement for opioids settlement), $Enphase Energy (ENPH.US)$ +9.5%, $Spotify Technology (SPOT.US)$ +9.2%, $RPC Inc (RES.US)$ +8.5%, $Chipotle Mexican Grill (CMG.US)$ +8.2%, $Manhattan Associates (MANH.US)$ +8.1%, $Hilton Worldwide (HLT.US)$ +6.7%, $ChampionX (CHX.US)$ +6.1%, $Mr. Cooper Group (COOP.US)$ +5.7%, $Constellium (CSTM.US)$ +5.5%, $Boston Scientific (BSX.US)$ +5.4%, ...
No comment yet